News Release 2-Oct-2024 Peer-Reviewed PublicationUniversity of Rochester Medical Center Age-related macular degeneration (AMD) is a leading cause of irreversible vision loss in the United States. Despite existing treatments, the underlying causes of this disease and effective therapies remain elusive. New research published in the journal Developmental Cell provides important insights into the cellular mechanisms behind...
Tag: <span>Ophthalmology</span>
Post
Is gene therapy the next big step in vision loss treatment?
Diseases that affect the retina, the light-sensitive layer at the back of the eye, are a significant cause of visual impairment and blindness. Gene therapy holds promise for treating some of these conditions, and current research advances may soon shift the therapeutic landscape for eye health. However, many obstacles remain in place, as this Special...
Post
Common diabetes drug shows promise for treating macular degeneration
October 1, 2024 by University of Chicago Medical Center Age-related macular degeneration (AMD) is one of the leading causes of vision loss in adults over 50 in the United States. According to estimates from the National Eye Institute, approximately 11 million people in the U.S. are affected by some form of AMD, and that number...
Post
AI tool uses eye imaging datasets to optimize diabetic eye screening
September 12, 2024 by King’s College London Deep learning system training schema for the 2 year prediction interval. Credit: Communications Medicine (2024). DOI: 10.1038/s43856-024-00590-zResearchers at King’s College London have used anonymized NHS eye data from more than 100,000 people with diabetes to build an AI model that can accurately predict who is at a high...
Post
100-fold improvement in sight seen after gene therapy trial
September 5, 2024 by Perelman School of Medicine at the University of Pennsylvania Credit: Unsplash/CC0 Public Domain The vision of people with a rare inherited condition that causes them to lose much of their sight early in childhood was 100 times better after they received gene therapy to address the genetic mutation causing it. Some...
Post
Researchers discover potential therapeutic target for degenerative eye disease
July 26, 2024 by National Institutes of Health Akt2 upregulation triggers lysosomal dysfunction and an AMD-like phenotype in mice. Credit: Nature Communications (2024). DOI: 10.1038/s41467-024-50500-zResearchers from the National Institutes of Health (NIH) have discovered the source of dysfunction in the process whereby cells in the eye’s retina remove waste. A report by scientists at NIH...
Post
Robot radiotherapy could improve treatments for eye disease
JUNE 11, 2024 by King’s College London Credit: Pixabay/CC0 Public DomainResearchers from King’s College London, with doctors at King’s College Hospital NHS Foundation Trust, have successfully used a new robot system to improve treatment for a debilitating eye disease. The custom-built robot was used to treat wet neovascular age-related macular degeneration (AMD), administering a one-off,...
Post
Novel approach reverses amblyopia in animals
by Massachusetts Institute of Technology Credit: Unsplash/CC0 Public Domain Amblyopia is the most common cause of vision loss in children, according to the U.S. National Eye Institute. It arises when visual experience is disrupted during infancy, for example by a cataract in one eye. Even after the cataract is removed, vision through the affected eye is...
Post
Clinicians identify pink eye as possible primary symptom of COVID-19
by University of Alberta Faculty of Medicine & Dentistry A case of pink eye is now reason to be tested for COVID-19, according to University of Alberta researchers. Coughing, fever and difficulty breathing are common symptoms of the illness, but a recent case study involving an Edmonton woman and published in the Canadian Journal of...
Post
Could a drug combination prevent people with the eye disease uveitis lose their sight?
Two in 10,000 people are at risk of serious sight loss from a form of eye inflammation known as uveitis. A new clinical research study, led by the University of Bristol and University Hospitals Bristol and Weston NHS Foundation Trust (UHBW), will evaluate a drug combination treatment for the eye disease thanks to the funding...
- 1
- 2